In this podcast, Chris interviews Mary Mihalyo, CEO & Co-founder of Delta Care RX.  Mary has a rich history of teaching and helping to improve the care delivery of the hospice and palliative care segment via pharmacotherapy management, options and expertise.  

Mary through her expertise and then later through helping to co-found Delta Care RX has helped hospice and palliative care organizations since 1999 save dollars and at the same time improve quality hospice care.  This win-win has enabled hospice programs to reinvest in their missions in significant ways.  Mary also shares some future innovations in the pharmacotherapy area that we might look forward to.

A great quote from the podcast from Mary, “The more things change in hospice pharmaceutical care the more they stay the same.  Many of the national medication related issues we are dealing with today are the same as what we dealt with decades ago. Hospices with a solid pharmaceutical care infrastructure likely fare better.”

This is a great listen for staff, leaders, and Board’s of hospice and palliative care organizations.  Join us, this is timely and relevant.  

"It is not immoral or unethical to think about the cost of therapy.  In fact, the cost of therapy should be recognized regardless of the environment of care."  – Mary Mihalyo

Guest: Mary Mihalyo, PharmD, BCPS; CEO & Co-founder of Delta Care RX

Host:  Chris Comeaux, President / CEO of TCN

www.teleioscn.org

Teleios Collaborative Network / https://www.teleioscn.org/tcntalkspodcast